Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis. | Gut;60(11): 1520-6, 2011 Nov. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis.

Leiper, Keith; Martin, Kate; Ellis, Anthony; Subramanian, Sreedhar; Watson, Alastair J; Christmas, Steve E; Howarth, Deborah; Campbell, Fiona; Rhodes, Jonathan M.

Affiliation

Leiper K; Department of Gastroenterology, University of Liverpool, Liverpool, UK.

Gut ; 60(11): 1520-6, 2011 Nov.

Article in En | MEDLINE | ID: mdl-21471566

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colitis, Ulcerative / Antigens, CD20 / Antibodies, Monoclonal, Murine-Derived Type of study: Clinical_trials Limits: Adult / Female / Humans / Middle aged Language: En Journal: Gut Year: 2011 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colitis, Ulcerative / Antigens, CD20 / Antibodies, Monoclonal, Murine-Derived Type of study: Clinical_trials Limits: Adult / Female / Humans / Middle aged Language: En Journal: Gut Year: 2011 Document type: Article Affiliation country: Country of publication: